1-6 of 6
Alexey V. Danilov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bruton Tyrosine Kinase Degraders in B-Cell Malignancies

Tiana Huynh, Sonia Rodriguez-Rodriguez, Alexey V. Danilov
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (5): 619–626.
https://doi.org/10.1158/1535-7163.MCT-23-0520
Published: 02 May 2024
View article titled, Bruton Tyrosine Kinase Degraders in B-Cell Malignancies
Open the PDF for Bruton Tyrosine Kinase Degraders in B-Cell Malignancies in another window
Journal Articles

T Cell–intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia

Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss, Scott Best, Xiaoguang Wang, Tycel Phillips, Geoffrey Shouse, Allison J. Berger, Lapo Alinari, Lili Wang, Tanya Siddiqi, Nathan D. Pennock, Alexey V. Danilov
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (9): 1040–1051.
https://doi.org/10.1158/1535-7163.MCT-22-0762
Published: 05 September 2023
View article titled, T Cell–intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia
Open the PDF for T Cell–intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers

Masanori Kawakami, Lisa Maria Mustachio, Yulong Chen, Zibo Chen, Xiuxia Liu, Cheng-Hsin Wei, Jason Roszik, Adam S. Kittai, Alexey V. Danilov, Xiaoshan Zhang, Bingliang Fang, Jing Wang, John V. Heymach, Liliya Tyutyunyk-Massey, Sarah J. Freemantle, Jonathan M. Kurie, Xi Liu, Ethan Dmitrovsky
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (3): 477–489.
https://doi.org/10.1158/1535-7163.MCT-19-0987
Published: 02 March 2021
View article titled, A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
Open the PDF for A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers in another window
Includes: Supplementary data
Journal Articles

Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma

Taylor Hashiguchi, Nur Bruss, Scott Best, Vi Lam, Olga Danilova, Cody J. Paiva, Joelle Wolf, Erin W. Gilbert, Craig Y. Okada, Prabhjot Kaur, Lisa Drew, Justin Cidado, Peter Hurlin, Alexey V. Danilov
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (9): 1520–1532.
https://doi.org/10.1158/1535-7163.MCT-18-1023
Published: 03 September 2019
View article titled, Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma
Open the PDF for Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2

Alexey V. Danilov, Shanhu Hu, Bernardo Orr, Kristina Godek, Lisa Maria Mustachio, David Sekula, Xi Liu, Masanori Kawakami, Faye M. Johnson, Duane A. Compton, Sarah J. Freemantle, Ethan Dmitrovsky
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (11): 2758–2766.
https://doi.org/10.1158/1535-7163.MCT-16-0127
Published: 01 November 2016
View article titled, Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2
Open the PDF for Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2 in another window
Includes: Multimedia, Supplementary data
Journal Articles

Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737

Darcy J.P. Bates, Alexey V. Danilov, Christopher H. Lowrey, Alan Eastman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1504–1514.
https://doi.org/10.1158/1535-7163.MCT-12-1197
Published: 08 August 2013
View article titled, Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737
Open the PDF for Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737 in another window
Includes: Supplementary data